semaglutide clinic in rest haven If you're thinking about stopping weight loss injections, you're not alone A new study is raising

Rheumatology International, 31 (12), 15451547

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have shown much potential for lowering blood sugar, but little is known about whether the oral form of semaglutide actually decreases major cardiovascular events, such as heart attacks and stroke

Novo Nordisk spent years and billions of dollars developing semaglutide, conducting extensive clinical trials involving thousands of participants over multiple years

doi: 10.1089/thy.2017.0102 19 ChaudharyBElkordE

Results vary, but studies show average weight loss of 1522% of body weight

Ettehad D, Emdin CA, Kiran A, et al